References
British Thoracic Association. Death from asthma in two regions of England. British Medical Journal 285: 1251–1255, 1982
Burgess C, Beasley R, Pearce N, Crane J. Prescribing of fenoterol and severity of asthma. Correspondence. New Zealand Medical Journal 103: 21–22, 1990
Crane J, Pearce N, Flatt A, Burgess C, Jackson R, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981–83: case-control study. Lancet 1: 917–922, 1989
Elwood JM. Prescribed fenoterol and deaths from asthma in New Zealand: second report. Department of Preventive and Social Medicine, University of Otago, Dunedin, 1989
Huhti E, Poukkula A. Clinical comparison of fenoterol and albuterol administered by inhalation: a double-blind study. Chest 73: 348–351, 1978
Jackson R, Sears MR, Beaglehole R, Rea HH. International trends in asthma mortality: 1970–1985. Chest 94: 914–919, 1988
Jackson RT, Beaglehole R, Rea HH, Sutherland DC. Mortality from asthma: a new epidemic in New Zealand. British Medical Journal 285: 771–774, 1982
Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on bronchial responsiveness in children with asthma. Journal of Allergy and Clinical Immunology 79: 653–659, 1987
Kraan J, Koeter GH, Mark Th Wvd, Sluiter HJ, de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. Journal of Allergy and Clinical Immunology 76: 628–636, 1985
O’Donnell TV. Asthma: Australia and New Zealand. Australian and New Zealand Journal of Medicine 18: 303–310, 1988
O’Donnell TV, Rea HH, Holst PE, Sears MR. Fenoterol and fatal asthma. Correspondence. Lancet 1: 1070–1071, 1989
Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, et al. Casecontrol study of prescribed fenoterol and death from asthma in New Zealand, 1977–81. Thorax 45: 170–175, 1990
Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, et al. A case-control study of deaths from asthma. Thorax 41: 833–839, 1986
Sears MR. Prescribing of fenoterol and severity of asthma. Correspondence. New Zealand Medical Journal 103: 21, 1990
Sears MR, Rea HH, Beaglehole R, Gillies AJ, Hoist PE, et al. Asthma mortality in New Zealand: a two year national study. New Zealand Medical Journal 98: 272–275, 1985
Speizer FE, Doll R, Heaf P. Observations on recent increase in mortality from asthma. British Medical Journal 1: 335–339, 1968
Tattersfield AE. Effect of beta-agonists and anticholinergic drugs on bronchial reactivity. American Review of Respiratory Disease 136: 64S-68S, 1987
Wilson JD, Sutherland DC, Thomas AC. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet 1: 1235–1237, 1981
Woolcock AJ. Worldwide differences in asthma prevalence and mortality: why is asthma mortality so low in the USA? Chest 90: 40S-45S, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woolcock, A.J. β-Agonists and Asthma Mortality. Drugs 40, 653–656 (1990). https://doi.org/10.2165/00003495-199040050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199040050-00001